Physician‐assessed changes in clinical signs · children with eczema
1 finding from 1 review
Secondary outcome: quality of life · children with eczema
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Secondary outcome: clinical flare · children with eczema
1 finding from 1 review
Change in burn‐related pruritus (VAS) ( · people with postburn pruritus
Gabapentin showed no clear difference in change in burn‐related pruritus (VAS) ( compared with cetirizine (antihistamine) (low certainty).
1 finding from 1 review
Somnolence · people with postburn pruritus
Gabapentin may leads to lower adverse events (somnolence) compared with cetirizine (antihistamine) (low certainty).
1 finding from 1 review
Pain · people with postburn pruritus
The review found no eligible studies for this question.
1 finding from 1 review
Change in burn‐related pruritus (VAS) ( · people with postburn pruritus
Pregabalin showed no clear difference in change in burn‐related pruritus (VAS) ( compared with cetirizine with pheniramine maleate (antihistamine) (low certainty).
1 finding from 1 review
Adverse effects: drowsiness (gabapentin alone) · people with postburn pruritus
Pregabalin may leads to lower adverse events (drowsiness) compared with cetirizine with pheniramine maleate (antihistamine) (low certainty).
1 finding from 1 review
Pain · people with postburn pruritus
The review found no eligible studies for this question.
1 finding from 1 review
Complete cessation of urticaria Global assessment of symptom scores · patients with chronic spontaneous urticaria
Loratadine 10 mg showed no clear difference in complete cessation of urticaria Global assessment of symptom scores compared with cetirizine 10 mg (low certainty).
1 finding from 1 review